Pfizer Unit Recalls Pain Drug Embeda
Pfizer Inc.'s recently acquired subsidiary King Pharmaceuticals Inc. is recalling 100,000 bottles of pain medication Embeda from U.S. wholesalers and retailers, marking the fourth time in the last year that the...To view the full article, register now.
Already a subscriber? Click here to view full article